Mimics and chameleons of optic neuritis

Practical Neurology

Volumn 16, Issue 2, 2016, Pages 96-110

  Weerasinghe, Dinushi ^a,b   Lueck, Christian ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIAL DIAGNOSIS; HUMAN; NERVOUS SYSTEM DISEASES; OPTIC NEURITIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NERVOUS SYSTEM DISEASES; OPTIC NEURITIS;

EID: 84960960858     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2015-001254     Document Type: Review

References (68)

1. Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995;45:244–50.
2. Atkins EJ, Biousse V, Newman NJ. Optic neuritis. Semin Neurol 2007;3:211–19.
3. Horwitz H, Friis T, Modvig S, et al. Differential diagnoses to MS: experiences from an optic neuritis clinic. J Neurol 2014;261:98–105.
4. Wong SH, Cleary G, Storoni M, et al. ‘Blindness cured!’: long-standing visual loss responding to corticosteroids. Pract Neurol 2013;13:245–8.
5. Toosy AT, Miller DH. Optic neuritis. Lancet 2014;13:83–99.
6. Balcer LJ. Optic neuritis. New Eng J Med 2006;354:1273–80.
7. Beck RW, Cleary PA, Anderson MM, et al., the Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. New Eng J Med 1992;326:581–8.
8. [No authors listed]. The clinical profile of optic neuritis: experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 1991;109:1673–8.
9. Hickman SJ, Dalton CM, Miller DH, et al. Management of acute optic neuritis. Lancet 2002;360;1953–62.
10. Foroozan R, Buono LM, Savino PJ, et al. Acute demyelinating optic neuritis. Curr Opin Ophthalmol 2002;13:375–80.
11. Beck RW, Cleary PA, Optic neuritis treatment trial; one-year follow-up results. Arch Ophthalmol 1993;111:773–5.
12. Trobe JD, Beck RW, Moke PS, et al. Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Am J Ophthalmol 1996;121:547–53.
13. Katz B. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial. Trans Am Ophthalmol Soc 1995;93:685–708.
14. Keltner JL Johnson CA, Spurr JO, et al., Baseline visual field profile of optic neuritis: the experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 1993;111:231–4.
15. Keltner JL, Johnson CA, Cello KE, et al. for the Optic Neuritis Study Group. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol 2010;128: 330–7.
16. The Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis; final optic neuritis treatment trial follow-up. Arch Neurol 2008;65:727–32.
17. Lightman S, McDonald WI, Bird AC, et al. Retinal venous sheathing in optic neuritis; its significance for the pathogenesis of multiple sclerosis. Brain 1987;110:405–14.
18. Lim YM, Pyun SY, Lim HT, et al. First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis. Neurol Sci 2014;35:781–3.
19. Pula JH, Kattah JC, Keung B, et al. Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder. J Neurol Sci 2014;345:209–12.
20. Rolak LA, Beck RW, Paty DW, et al. for the Optic Neuritis Study Group. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology 1996;46:368p–72.
21. Levin MH, Bennett JL, Verkman AS. Optic neuritis in neuromyelitis optica. Prog Ret Eye Res 2013;36:159–71.
22. Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 2010;75:1423–7.
23. Lange AP, Sadjadi R, Zhu F, et al. Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients. J Neuro-Ophthalmolol 2013;33:213–19.
24. Bennett JL, de Seze J, Lana-Peixoto M, et al., GJCF-ICC&BR. Neuromyelitis optica and multiple sclerosis: seeing difference through optical coherence tomography. Mult Scler 2015;21:678–88.
25. Mealy MA, Whetstone A, Orman G, et al. Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. J Neurol Sci 2015;355:59–63.
26. Ramanathan S, Reddel SW, Henderson A, et al. Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm 2014;1: e40;
27. Nakajima H, Motomura M, Tanaka K, et al. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. BMJ Open 2015;5:e007766.
28. Galetta SL, Cornblath WT. Should most patients with optic neuritis be tested for neuromyelitis optica antibodies and should this affect their treatment? J Neuro-Ophthalmol 2010;30:376–9.
29. Frohman LP, Guirgis M, Turbin RE, et al. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuro-Ophthalmol 2003;23:190–7.
30. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis—diagnosis and management. Q J Med 1999;92:103–17.
31. Terushkin V, Stern BJ, Judson MA, et al. Neurosarcoidosis: presentations and management. Neurologist 2010;16:2–15.
32. Kidd D. Inflammatory optic neuropathies not associated with multiple sclerosis. In: Kidd DP, Newman NJ, Biousse V, eds. Neuro-ophthalmology. Philadelphia: Butterworth-Heinemann, 2008:153–90.
33. Kidd D, Burton B, Plant GT, et al. Chronic relapsing inflammatory optic neuropathy (CRION). Brain 2003;126:276–84.
34. Petzold A, Pittock S, Lennon V, et al. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 2010;81:109–11.
35. Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 2014;261:17–26.
36. Biousse V, Newman NJ. Ischemic optic neuropathies. New Eng J Med 2015;372:2428–36.
37. Purvin V, Kawasaki A, Jacobson DM. Optic perineuritis: clinical and radiographic features. Arch Ophthalmol 2001;119:1299–306.
38. Rappoport D, Goldenberg-Cohen N, Luckman J, et al. Parainfectious optic neuritis: manifestations in children vs. adults. J Neuro-Ophthalmol 2014;34:122–9.
39. Miller NR, Newman NJ, Biousse V, et al., eds. Wash & Hoyt’s clinical neuro-ophthalmology. 6th edn, Vol 3. Philadelphia: Lippincott Williams & Wilkins, 2005.
40. Thurtell MJ, Chiu ALS, Goold LA, et al. neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature. Clin Exp Ophthalmol 2013;41:567–76.
41. Matsuo T, Notohara K, Yamadori I. Aspergillosis causing bilateral optic neuritis and later orbital apex syndrome. Jpn J Ophthalmol 2005;49:423–33.
42. Alsuhaibani AH, Al-Thubaiti G, Al Badr FB. Optic nerve thickening and infarction as the first evidence of orbital involvement with mucormycosis. Middle East Afr J Ophthalmol 2012;19:340–2.
43. Gass JD.. Diseases of the optic nerve that may simulate macular disease. Trans Am Acad Ophthalmol Otolaryngol 1977;83:766–9.
44. Purvin V, Sundaram S, Kawasaki A. Neuroretinitis: review of the literature and new observations. J Neuro-Ophthalmol 2011;31:58–68.
45. Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 2010;55:299–334.
46. Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber’s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial mutation. Brain 1995;118:319–37.
47. Hsu TK, Wang AG, Yen MY, et al. Leber’s hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery. Clin Exp Optom 2014;97:84–6.
48. Palace J. Multiple sclerosis associated with Leber’s hereditary optic neuropathy. J Neurol Sci 2009;286:24–7.
49. Matthews L, Enzinger C, Fazekas F, et al., on behalf of the MAGNIMS project. MRI in Leber’s hereditary optic neuropathy: the relationship to multiple sclerosis. J Neurol Neurosurg Psychiatry 2015;86:537–42.
50. Gass JD. Acute zonal occult outer retinopathy. J Clin Neuroophthalmol 1993;13:79–97.
51. Mrejen S, Khan S, Gallego-Pinazo R, et al. Acute zonal occult outer retinopathy: a classification based on multimodal imaging. JAMA Ophthalmol 2014;132:1089–98.
52. Monson DM, Smith JR. Acute zonal occult outer retinopathy. Surv Ophthalmol 2011;56:23–35.
53. Gross NE, Yannuzzi LA, Freund B, et al. Multiple evanescent white dot syndrome. Arch Ophthalmol 2006;124:493–500.
54. Jampol LM, Sieving PA, Pugh D, et al. Multiple evanescent white dot syndrome; 1. Clinical findings. Arch Ophthalmol 1984;102:671–4.
55. Volpe NJ, Rizzo JF, Lessell S. Acute idiopathic blind spot enlargement syndrome; a review of 27 new cases. Arch Ophthalmol 2001;119:59–63.
56. Watzke RC, Shults WT. Clinical features and natural history of the acute idiopathic enlarged blind spot syndrome. Ophthalmology 2002;109:1326–35.
57. Fletcher WA, Imes RK, Goodman D, et al. Acute idiopathic blind spot enlargement. Arch Ophthalmol 1988;106:44–9.
58. Almeida DRP, Chin EK, Niles P, et al. Unilateral manifestation of autoimmune retinopathy. Can J Ophthalmol 2014;49: e85–7.
59. Mizener JB, Kimura AE, Adamus G, et al. Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol 1997;123:607–18.
60. Thirkill CE, FitzGerald P, Sergott RC, et al. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. New Eng J Med 1989;321:1589–94.
61. Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuro-Ophthalmol 2001;21:173–87.
62. Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary. Semin Immunopathol 2008;30: 127–34.
63. Quin G, Liew G, Ho IV, et al. Diagnosis and interventions for central serous chorioretinopathy: review and update. Clin Exp Ophthalmol 2013;41:187–200.
64. Liegl R, Ulbig MW. Central serous chorioretinopathy. Ophthalmologica 2014;232:65–76.
65. Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol 2008;86:126–45.
66. Liew G, Quin G, Gillies M, et al. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exp Ophthalmol 2013;41:201–14.
67. Atkins EJ, Newman NJ, Biousse V. Lesions of the optic nerve. In: Kennard C, Leigh RJ, eds. Handbook of clinical neurology: neuro-ophthalmology. Amsterdam: Elsevier, 2011:159–84.
68. Petzold A, Plant GT. Diagnosis and classification of autoimmune optic neuropathy. Autoimmunity Rev 2014;13:539–45.